Compile Data Set for Download or QSAR
Report error Found 113 Enz. Inhib. hit(s) with all data for entry = 7008
TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166059BDBM166059(US9067937, 2)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166100BDBM166100(US9067937, 44)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 60438BDBM60438(US9067937, 28)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166117BDBM166117(US9067937, 61)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166154BDBM166154(US9067937, 202)
Affinity DataIC50: 0.460nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166137BDBM166137(US9067937, 81)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166072BDBM166072(US9067937, 15)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166061BDBM166061(US9067937, 4)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166127BDBM166127(US9067937, 71)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166150BDBM166150(US9067937, 94)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166104BDBM166104(US9067937, 48)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166136BDBM166136(US9067937, 80)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166145BDBM166145(US9067937, 89)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166126BDBM166126(US9067937, 70)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166066BDBM166066(US9067937, 9)
Affinity DataIC50: 0.700nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166084BDBM166084(US9067937, 27)
Affinity DataIC50: 0.700nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166119BDBM166119(US9067937, 63)
Affinity DataIC50: 0.800nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166062BDBM166062(US9067937, 5)
Affinity DataIC50: 0.800nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166118BDBM166118(US9067937, 62)
Affinity DataIC50: 0.900nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166071BDBM166071(US9067937, 14)
Affinity DataIC50: 0.900nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166153BDBM166153(US9067937, 201)
Affinity DataIC50: 0.930nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166105BDBM166105(US9067937, 49)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166139BDBM166139(US9067937, 83)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166069BDBM166069(US9067937, 12)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166131BDBM166131(US9067937, 75)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166149BDBM166149(US9067937, 93)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166165BDBM166165(US9067937, 213)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166063BDBM166063(US9067937, 6)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166123BDBM166123(US9067937, 67)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166060BDBM166060(US9067937, 3)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166120BDBM166120(US9067937, 64)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166113BDBM166113(US9067937, 57)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166125BDBM166125(US9067937, 69)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166096BDBM166096(US9067937, 40)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166156BDBM166156(US9067937, 204)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166166BDBM166166(US9067937, 214)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166158BDBM166158(US9067937, 206)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166064BDBM166064(US9067937, 7)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166070BDBM166070(US9067937, 13)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166162BDBM166162(US9067937, 210)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166067BDBM166067(US9067937, 10)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166155BDBM166155(US9067937, 203)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166065BDBM166065(US9067937, 8)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166109BDBM166109(US9067937, 53)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166135BDBM166135(US9067937, 79)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166088BDBM166088(US9067937, 32)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166164BDBM166164(US9067937, 212)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166159BDBM166159(US9067937, 207)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166097BDBM166097(US9067937, 41)
Affinity DataIC50: 1.70nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetMaternal embryonic leucine zipper kinase(Human)
Oncotherapy Science

US Patent
LigandChemical structure of BindingDB Monomer ID 166169BDBM166169(US9067937, 217)
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:MELK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

Displayed 1 to 50 (of 113 total ) | Next | Last >>
Jump to: